The fact (Campbell has reviewed the evidence in previous videos) the mRNA vaccine can travel from the vaccination site throughout the body is something I find horrific. And here he explains why it can be such a serious problem, especially for those with narrowing arteries in the heart and other vital areas. Scary stuff.
- π¦ mRNA vaccine for influenza is being discussed in the video.
- π©Έ Lipid nanoparticles in the vaccine can potentially be distributed throughout the body.
- π¬ The vaccine's lipid nanoparticles can merge with cell membranes and deliver RNA instructions.
- π‘οΈ The vaccine stimulates an immune response and an inflammatory response.
- πͺ Immune cells produce antibodies to protect against disease.
- π Systemic absorption of the vaccine and antigen production may vary based on the number of cells reached.
- βοΈ Controlling the dose of antigen produced and monitoring systemic inflammation is a concern.
- π The video questions why vaccine manufacturers haven't taken these concerns into account.
- π Governments around the world are investing in mRNA vaccine production with companies like Moderna and Oxford.
- β The video calls for answers regarding the potential systemic distribution and inflammatory effects of the vaccine.
- π₯ A follow-up video is mentioned for explaining the proposed details by the National Institutes of Health.